Pfizer Payout Strains: Income Investors Face Hard Truth
Pfizer paid more in dividends than its free cash flow in 2025, a warning sign for income investors facing hard realit...
Find out which cash back credit cards have no annual fee to suit your spending habits. Discover the perfect card for you today!
27,937 articlesPfizer paid more in dividends than its free cash flow in 2025, a warning sign for income investors facing hard realit...
Mortgage originations climbed to a three-year peak in Q4 2025, led by a refinancing wave that expanded affordability ...
When the next earnings season looms, a single well-chosen tech stock can outshine a broad, aimless portfolio. Learn h...
The S&P 500 has climbed about 9% in 2026 amid mixed signals. This guide breaks down what Wall Street expects next, pl...
A coming downgrade in the 2027 social security cola could shift retirement budgeting. This guide explains what it mea...
A fast IPO run can leave investors excited but unsure what comes next. We break down whether this stock soared 123% s...
Starting with $100 can feel tiny, but smart choices compound. This guide shows how to pick the best stock invest $100...
A high-profile shift at Base has changed the project’s direction. Jesse Pollak is stepping back from app leadership t...
A deadly cattle parasite remains largely uncontained as a key sterile-fly facility won’t be online until late 2027, r...
Retirees facing Medicare costs and market volatility are reconsidering Roth moves. Experts warn that large roth conve...
A year ago, a $1,000 investment in Newmont could have grown nicely as gold and miners moved. This article breaks down...
A new financial model could let investors earn dividends from gold royalties using tokenized gold. This piece explore...